Total properties:
27
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12444908
|
Filing Dt:
|
04/09/2009
|
Publication #:
|
|
Pub Dt:
|
03/04/2010
| | | | |
Title:
|
Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors
|
|
|
Patent #:
|
|
Issue Dt:
|
10/02/2012
|
Application #:
|
12746164
|
Filing Dt:
|
06/03/2010
|
Publication #:
|
|
Pub Dt:
|
10/28/2010
| | | | |
Title:
|
FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12863525
|
Filing Dt:
|
10/12/2010
|
Publication #:
|
|
Pub Dt:
|
02/10/2011
| | |
PCT #:
|
US2009032455
|
Title:
|
LIQUID FORMULATIONS OF COMPOUNDS ACTIVE AT SULFONYLUREA RECEPTORS
|
|
|
Patent #:
|
|
Issue Dt:
|
10/14/2014
|
Application #:
|
13610335
|
Filing Dt:
|
09/11/2012
|
Publication #:
|
|
Pub Dt:
|
09/19/2013
| | | | |
Title:
|
FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY
|
|
|
Patent #:
|
|
Issue Dt:
|
06/26/2018
|
Application #:
|
13779511
|
Filing Dt:
|
02/27/2013
|
Publication #:
|
|
Pub Dt:
|
03/20/2014
| | | | |
Title:
|
Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non-Selective CA++ Activated ATP-Sensitive Cation Channels Regulatd by SUR1 Channels
|
|
|
Patent #:
|
|
Issue Dt:
|
02/03/2015
|
Application #:
|
13811037
|
Filing Dt:
|
03/21/2013
|
Publication #:
|
|
Pub Dt:
|
08/08/2013
| | | | |
Title:
|
METHODS OF INTRAVENOUS ADMINISTRATION OF GLYBURIDE AND OTHER DRUGS
|
|
|
Patent #:
|
|
Issue Dt:
|
11/06/2018
|
Application #:
|
14508488
|
Filing Dt:
|
10/07/2014
|
Publication #:
|
|
Pub Dt:
|
05/21/2015
| | | | |
Title:
|
FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY
|
|
|
Patent #:
|
|
Issue Dt:
|
02/09/2016
|
Application #:
|
14525992
|
Filing Dt:
|
10/28/2014
|
Publication #:
|
|
Pub Dt:
|
06/11/2015
| | | | |
Title:
|
METHODS OF INTRAVENOUS ADMINISTRATION OF GLYBURIDE
|
|
|
Patent #:
|
|
Issue Dt:
|
02/07/2017
|
Application #:
|
14878232
|
Filing Dt:
|
10/08/2015
|
Publication #:
|
|
Pub Dt:
|
02/04/2016
| | | | |
Title:
|
METHODS OF INTRAVENOUS ADMINISTRATION OF GLYBURIDE
|
|
|
Patent #:
|
|
Issue Dt:
|
06/23/2020
|
Application #:
|
15094461
|
Filing Dt:
|
04/08/2016
|
Publication #:
|
|
Pub Dt:
|
08/03/2017
| | | | |
Title:
|
LIQUID FORMULATIONS OF COMPOUNDS ACTIVE AT SULFONYLUREA RECEPTORS
|
|
|
Patent #:
|
|
Issue Dt:
|
08/21/2018
|
Application #:
|
15425874
|
Filing Dt:
|
02/06/2017
|
Publication #:
|
|
Pub Dt:
|
11/23/2017
| | | | |
Title:
|
Methods of Intravenous Administration of Glyburide
|
|
|
Patent #:
|
|
Issue Dt:
|
01/26/2021
|
Application #:
|
15577273
|
Filing Dt:
|
11/27/2017
|
Publication #:
|
|
Pub Dt:
|
06/07/2018
| | | | |
Title:
|
METHODS OF REDUCING OR PREVENTING INTIMAL DAMAGE CAUSED BY MECHANICAL STIMULATION OF ENDOTHELIAL CELLS
|
|
|
Patent #:
|
|
Issue Dt:
|
08/27/2019
|
Application #:
|
15686989
|
Filing Dt:
|
08/25/2017
|
Publication #:
|
|
Pub Dt:
|
12/07/2017
| | | | |
Title:
|
METHODS OF INTRAVENOUS ADMINISTRATION OF GLYBURIDE
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15763932
|
Filing Dt:
|
11/08/2018
|
Publication #:
|
|
Pub Dt:
|
10/04/2018
| | | | |
Title:
|
METHODS OF TREATING INJURIES OR CONDITIONS RELATED TO CNS EDEMA
|
|
|
Patent #:
|
|
Issue Dt:
|
10/15/2019
|
Application #:
|
15989738
|
Filing Dt:
|
05/25/2018
|
Publication #:
|
|
Pub Dt:
|
09/27/2018
| | | | |
Title:
|
COMPOSITION CONTAINING GLIBENCLAMIDE
|
|
|
Patent #:
|
|
Issue Dt:
|
10/01/2019
|
Application #:
|
16138173
|
Filing Dt:
|
09/21/2018
|
Publication #:
|
|
Pub Dt:
|
04/04/2019
| | | | |
Title:
|
FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY
|
|
|
Patent #:
|
|
Issue Dt:
|
04/19/2022
|
Application #:
|
16321149
|
Filing Dt:
|
01/28/2019
|
Publication #:
|
|
Pub Dt:
|
06/13/2019
| | | | |
Title:
|
METHODS OF MEDICAL TREATMENT WITH SUR1-TRPM4 CHANNEL INHIBITORS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16321240
|
Filing Dt:
|
01/28/2019
|
Publication #:
|
|
Pub Dt:
|
06/06/2019
| | | | |
Title:
|
METHODS OF TREATING OR PREVENTING AMYLOID RELATED IMAGING ABNORMALITIES ASSOCIATED WITH ALZHEIMER'S DISEASE TREATMENT
|
|
|
Patent #:
|
|
Issue Dt:
|
09/29/2020
|
Application #:
|
16459893
|
Filing Dt:
|
07/02/2019
|
Publication #:
|
|
Pub Dt:
|
10/31/2019
| | | | |
Title:
|
METHODS OF INTRAVENOUS ADMINISTRATION OF GLYBURIDE
|
|
|
Patent #:
|
|
Issue Dt:
|
12/22/2020
|
Application #:
|
16585255
|
Filing Dt:
|
09/27/2019
|
Publication #:
|
|
Pub Dt:
|
03/26/2020
| | | | |
Title:
|
FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY
|
|
|
Patent #:
|
|
Issue Dt:
|
09/01/2020
|
Application #:
|
16599327
|
Filing Dt:
|
10/11/2019
|
Publication #:
|
|
Pub Dt:
|
03/26/2020
| | | | |
Title:
|
COMPOSITION CONTAINING GLIBENCLAMIDE
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17004448
|
Filing Dt:
|
08/27/2020
|
Publication #:
|
|
Pub Dt:
|
04/22/2021
| | | | |
Title:
|
COMPOSITION CONTAINING GLIBENCLAMIDE
|
|
|
Patent #:
|
|
Issue Dt:
|
01/24/2023
|
Application #:
|
17030925
|
Filing Dt:
|
09/24/2020
|
Publication #:
|
|
Pub Dt:
|
05/27/2021
| | | | |
Title:
|
METHODS OF INTRAVENOUS ADMINISTRATION OF GLYBURIDE
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17126993
|
Filing Dt:
|
12/18/2020
|
Publication #:
|
|
Pub Dt:
|
08/12/2021
| | | | |
Title:
|
FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY
|
|
|
Patent #:
|
|
Issue Dt:
|
04/09/2024
|
Application #:
|
17488591
|
Filing Dt:
|
09/29/2021
|
Publication #:
|
|
Pub Dt:
|
04/28/2022
| | | | |
Title:
|
METHODS OF TREATING INJURIES OR CONDITIONS RELATED TO CNS EDEMA
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17542830
|
Filing Dt:
|
12/06/2021
|
Publication #:
|
|
Pub Dt:
|
03/24/2022
| | | | |
Title:
|
METHODS OF MEDICAL TREATMENT WITH SUR1-TRPM4 CHANNEL INHIBITORS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18157302
|
Filing Dt:
|
01/20/2023
|
Publication #:
|
|
Pub Dt:
|
12/28/2023
| | | | |
Title:
|
METHODS OF INTRAVENOUS ADMINISTRATION OF GLYBURIDE
|
|